← Browse by Condition
Medical Condition

ckd

Total Trials
5
Recruiting Now
5
Trial Phases
Phase 2, Phase 3

ClinicalMetric tracks all active clinical trials for ckd sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — ckd Clinical Trials

How many clinical trials are currently recruiting for ckd?
ClinicalMetric currently tracks 5 actively recruiting clinical trials for ckd, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 5. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for ckd?
ckd research spans Phase 2 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a ckd clinical trial?
Eligibility criteria for ckd trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
1
Phase 3
1
Top Sponsors
University Medical Center Groningen 1 trial
Renibus Therapeutics, Inc. 1 trial
Ospedale San Raffaele 1 trial
Heart Care Foundation 1 trial
Chungnam National University Hospital 1 trial

Recruiting Clinical Trials

NCT07304817 Phase 2
Recruiting
Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)
Enrollment
100 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT07355062 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Veverimer for the Treatment of Metabolic Acidosis
Enrollment
150 pts
Location
United States
Sponsor
Renibus Therapeutics, Inc.
View Trial →
NCT06416761
Recruiting
Genetics in the Progression of Nephropathies
Enrollment
10,000 pts
Location
Italy
Sponsor
Ospedale San Raffaele
View Trial →
NCT06775028
Recruiting
Integrated Approach in Frail Older People with Atrial Fibrillation
Enrollment
1,250 pts
Location
Bulgaria, Denmark, I...
Sponsor
Heart Care Foundation
View Trial →
NCT07754097
Recruiting
Self-Management Data and Disease Progression in Chronic Kidney Disease
Enrollment
300 pts
Location
South Korea
Sponsor
Chungnam National University H...
View Trial →

Related Conditions

heart failure (2) hypertension (2) cardiovascular diseases (1) metabolic acidosis (1) aki (1) ckd mbd (1) ckd chronic kidney disease stage 5d (1) adpkd (1) hematologic malignancy (1) bone marrow transplant complications (1) atrial fibrillation af (1) coronary arterial disease cad (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology